Radiology procedure eases pain of uterine fibroids without adversely affecting fertility

May 05, 2003

Interventional radiology procedures are effective in treating uterine fibroids in patients who have symptoms of the disease without causing infertility or premature menopause, a new study shows.

Uterine fibroids are nourished by blood, says Hyun S. "Kevin" Kim, MD, of Johns Hopkins Medical Institutions in Baltimore and the lead author of the study. "We found that if we block the uterine and ovarian arteries feeding the fibroid, the patients symptoms are relieved," he says. The arteries are blocked (embolized) using special particles or spheres of varying size, notes Dr. Kim. "Larger particles were used to stop the flow of blood. When calibrated spheres were used, there was a significant reduction in the flow of blood," he adds.

In the study, ovarian artery embolization and uterine artery embolization was performed on six patients during the initial procedure. Both procedures were done on these patients because the arteries were connected, that is, blood was flowing from one artery to the other. Three other patients were treated by ovarian artery embolization for residual fibroids after the initial procedure, says Dr. Kim. One patient underwent ovarian artery emobolization for residual bulky fibroids on both ovaries, he adds.

"Symptomatic improvement was seen in all nine patients," he says. When blood flow is cut off to an organ, there is concern that the organ will die; however, no "premature ovarian failure was detected," says Dr. Kim. Some patients have been followed for up to a year, and all patients have reported normal menstrual periods. The patients have experienced no significant hormonal changes, he adds.
-end-
Dr. Kim will present his study on May 5 during the American Roentgen Ray Society Annual Meeting in San Diego.

Additional Contact Information:
Danica Laub (703) 858-4332
Keri Sperry (703) 858-4306
Press Room (619) 525-6536 (May 5-8)


American College of Radiology

Related Uterine Fibroids Articles from Brightsurf:

Artificial tissue used to research uterine contractions
Throughout an individual's lifetime, the uterus undergoes spontaneous contractions of the uterine wall, which can induce uterine peristalsis, a specific wavelike contraction pattern.

New targeted agent produces considerable responses in patients with uterine cancer
The DNA repair-blocking drug adavosertib shrinks tumors in nearly one-third of patients in clinical trial data to be shared at the Society for Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer.

Comparing effectiveness of 2 surgical methods for uterine prolapse
Uterine prolapse happens when weakened muscles and ligaments no longer provide enough support for the uterus, which then protrudes into or out of the vagina.

Uterine artery embolization can be considered for well controlled symptomatic leiomyomas
A new study published in the April 2019 issue of the American Journal of Roentgenology (AJR) investigates the safety of uterine artery embolization (UAE) for symptomatic leiomyomas in patients with various autoimmune diseases.

TGF-beta pathway protects against uterine cancer
Two new mouse models of uterine cancer reveal that the TGF-beta signaling pathway in uterine cells protects against the disease by suppressing the overgrowth and oncogenesis of the endometrium, the membrane lining the inside of the uterus.

Elagolix reduces menstrual bleeding from most common uterine tumors
A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

Uterine cancer survivors are more likely to have cardiovascular problems
A new study in the Journal of the National Cancer Institute indicates that survivors of uterine cancer are more likely to experience cardiovascular problems years after treatment.

New drug combo improves survival of women with rare uterine cancer
Adding the monoclonal antibody drug trastuzumab -- already used to treat certain breast cancers -- to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value

A new tool for improving uterine transplant surgery
Future Science Group (FSG) today announced the publication of an article in Future Science OA demonstrating the first use of multispectral imaging in gynecology, in a uterine transplant setting.

Study shows increased risk of uterine fibroids in African-American women with a common form of hair
In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids

Read More: Uterine Fibroids News and Uterine Fibroids Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.